We are live on !
Find out more
Glenview Trust Portfolio holdings
AUM
$7.42B
Turnover
11.48%
1-Year Est. Return
21.14%
Glenview Trust is a Kentucky trust company that works only with individuals and their families, offering investments, financial planning and trust and estate services. It is closely held and owned by its employees, and its professionals do not sell any products of their own. Scott Neff is its president and chief executive, and Bill Stone is its chief investment officer.
This Fund
S&P 500
This Quarter Est. Return
+2.32%
1 Year Est. Return
+21.14%
3 Year Est. Return
+109.55%
5 Year Est. Return
+139.27%
10 Year Est. Return
+451.35%
AUM
$1.29B
AUM Growth
+$22.8M
(+1.8%)
Cap. Flow
-$9.9K
Cap. Flow % of AUM
Cap. Flow %
-0%
Top 10 Holdings %
Top 10 Hldgs %
21.31%
Holding
323
New
6
Increased
83
Reduced
132
Closed
14
Avg Time Held
2.3
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$5.54M |
| 2 |
Danaher
DHR
|
+$3.36M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$2.07M |
| 4 |
First Trust North American Energy Infrastructure Fund
EMLP
|
+$1.3M |
| 5 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.34M |
| 2 |
NVIDIA
NVDA
|
+$2.14M |
| 3 |
Gilead Sciences
GILD
|
+$1.94M |
| 4 |
Perrigo
PRGO
|
+$1.36M |
| 5 |
Brown-Forman Class B
BF.B
|
+$860K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.27% |
| 2 | Technology | 14.62% |
| 3 | Consumer Staples | 13.2% |
| 4 | Healthcare | 13.18% |
| 5 | Financials | 12.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
iShares Core S&P 500 ETF
IVV
$871B
| $44.5M | 3.45% |
182,648
-9,709
| -5% | -$2.34M |
2013 Q4
14 quarters
|
|
2
Apple
AAPL
$5.03T
| $30.4M | 2.36% |
845,024
-16,716
| -2% | -$618K |
2013 Q4
14 quarters
|
|
3
IBM
IBM
$244B
| $28.8M | 2.23% |
195,509
-2,682
| -1% | -$404K |
2013 Q4
14 quarters
|
|
4
Procter & Gamble
PG
$374B
| $28.7M | 2.23% |
328,950
-8,387
| -2% | -$739K |
2013 Q4
14 quarters
|
|
5
JPMorgan Chase
JPM
$895B
| $27.9M | 2.17% |
305,789
-4,604
| -1% | -$397K |
2013 Q4
14 quarters
|
|
|
6
iShares MSCI EAFE ETF
EFA
$76.7B
| $27.8M | 2.16% |
426,200
+31,982
| +8% | +$2.07M |
2013 Q4
14 quarters
|
|
7
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $22.4M | 1.74% |
92,785
+778
| +0.8% | +$186K |
2013 Q4
14 quarters
|
|
8
ExxonMobil
XOM
$764B
| $22.3M | 1.73% |
275,923
-7,737
| -3% | -$633K |
2013 Q4
14 quarters
|
|
9
Johnson & Johnson
JNJ
$658B
| $21.1M | 1.64% |
159,300
-1,860
| -1% | -$237K |
2013 Q4
14 quarters
|
|
10
Coca-Cola
KO
$405B
| $20.7M | 1.61% |
461,067
-2,407
| -0.5% | -$106K |
2013 Q4
14 quarters
|
|
11
Microsoft
MSFT
$3.88T
| $20.6M | 1.6% |
299,313
-7,541
| -2% | -$518K |
2013 Q4
14 quarters
|
|
|
12
NVIDIA
NVDA
$4.94T
| $20.3M | 1.57% |
5,608,480
-674,280
| -11% | -$2.14M |
2014 Q4
10 quarters
|
|
13
Intel
INTC
$350B
| $19.9M | 1.54% |
589,119
-1,266
| -0.2% | -$45.3K |
2013 Q4
14 quarters
|
|
14
Mastercard
MA
$556B
| $19.8M | 1.54% |
163,204
-1,722
| -1% | -$204K |
2013 Q4
14 quarters
|
|
|
15
Brown-Forman Class B
BF.B
$13.2B
| $19.8M | 1.54% |
635,830
-27,414
| -4% | -$860K |
2013 Q4
14 quarters
|
|
16
Chevron
CVX
$459B
| $19.4M | 1.51% |
185,828
+1,375
| +0.7% | +$146K |
2013 Q4
14 quarters
|
|
17
Cisco
CSCO
$412B
| $17.8M | 1.38% |
568,157
+7,074
| +1% | +$230K |
2013 Q4
14 quarters
|
|
18
iShares MSCI Emerging Markets ETF
EEM
$28.3B
| $17.3M | 1.34% |
417,689
+2,724
| +0.7% | +$111K |
2013 Q4
14 quarters
|
|
19
Roper Technologies
ROP
$46.1B
| $16.6M | 1.29% |
71,683
-901
| -1% | -$199K |
2013 Q4
14 quarters
|
|
20
iShares Russell Mid-Cap ETF
IWR
$57.2B
| $16.6M | 1.29% |
345,272
+8,840
| +3% | +$419K |
2013 Q4
14 quarters
|
|
21
AbbVie
ABBV
$521B
| $16.5M | 1.28% |
227,967
-4,774
| -2% | -$321K |
2013 Q4
14 quarters
|
|
22
Philip Morris
PM
$325B
| $16.3M | 1.26% |
138,457
-737
| -0.5% | -$85.4K |
2013 Q4
14 quarters
|
|
23
Verizon
VZ
$185B
| $16M | 1.24% |
357,408
+1,778
| +0.5% | +$82.8K |
2013 Q4
14 quarters
|
|
24
Lowe's Companies
LOW
$117B
| $15.4M | 1.2% |
198,677
-3,223
| -2% | -$263K |
2013 Q4
14 quarters
|
|
25
Unum
UNM
$14.4B
| $14.4M | 1.12% |
309,109
-2,813
| -0.9% | -$129K |
2014 Q4
10 quarters
|
|
Similar funds
Glenview Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Glenview Trust held 323 positions worth $1.29B, up 1.8% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Glenview Trust's Q2 2017 filing shows 6 new, 83 increased, 132 reduced and 14 closed positions. Its largest new stake was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 116,167 shares worth $5.59M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.
- Glenview Trust's largest Q2 2017 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 116,167 shares worth $5.59M.
- Glenview Trust added most to Danaher in Q2 2017, an estimated $3.36M increase.
- Glenview Trust's biggest Q2 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.34M.
- Glenview Trust fully exited iShares iBonds Dec 2017 Term Corporate ETF in Q2 2017, selling an estimated $417K.
- Glenview Trust's ten largest holdings make up 21% of its $1.29B portfolio in Q2 2017.
- Glenview Trust opened 6 new positions and closed 14 in Q2 2017.
- Glenview Trust's portfolio value rose 1.8% quarter-over-quarter to $1.29B.
Based on Glenview Trust's 13F filing for Q2 2017, filed 11 Aug 2017.